BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32316844)

  • 1. Current opinion on hydroxychloroquine-related retinal toxicity screening: where do we stand now?
    Aduriz-Lorenzo PM; Aduriz-Llaneza P; Araiz-Iribarren J; Khamashta MA
    Lupus; 2020 Jun; 29(7):671-675. PubMed ID: 32316844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.
    Marmor MF; Kellner U; Lai TY; Lyons JS; Mieler WF;
    Ophthalmology; 2011 Feb; 118(2):415-22. PubMed ID: 21292109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Demise of the Bull's Eye (Screening for Hydroxychloroquine Retinopathy).
    Marmor MF
    Retina; 2016 Oct; 36(10):1803-5. PubMed ID: 27388736
    [No Abstract]   [Full Text] [Related]  

  • 4. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology.
    Marmor MF; Carr RE; Easterbrook M; Farjo AA; Mieler WF;
    Ophthalmology; 2002 Jul; 109(7):1377-82. PubMed ID: 12093666
    [No Abstract]   [Full Text] [Related]  

  • 5. Hydroxychloroquine Screening Alert: Change is in the Wind.
    Marmor MF
    Ophthalmic Surg Lasers Imaging Retina; 2017 Feb; 48(2):96-98. PubMed ID: 28195610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the revised american academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practice.
    Browning DJ
    Am J Ophthalmol; 2013 Mar; 155(3):418-428.e1. PubMed ID: 23218706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
    Michaelides M; Stover NB; Francis PJ; Weleber RG
    Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Night Blindness, Ring Scotoma, and a Nonrecordable Electroretinogram in an Elderly Woman.
    Grassi MA; Maker MP; Marmor MF
    JAMA Ophthalmol; 2019 Jan; 137(1):109-110. PubMed ID: 30452517
    [No Abstract]   [Full Text] [Related]  

  • 9. Rapid Onset of Retinal Toxicity From High-Dose Hydroxychloroquine Given for Cancer Therapy.
    Leung LS; Neal JW; Wakelee HA; Sequist LV; Marmor MF
    Am J Ophthalmol; 2015 Oct; 160(4):799-805.e1. PubMed ID: 26189086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Diagnostic Utility of Multifocal Electroretinography in Detecting Chloroquine and Hydroxychloroquine Retinal Toxicity.
    Tsang AC; Ahmadi S; Hamilton J; Gao J; Virgili G; Coupland SG; Gottlieb CC
    Am J Ophthalmol; 2019 Oct; 206():132-139. PubMed ID: 31078540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to set up a Hydroxychloroquine Retinopathy Screening Service.
    Zaidi FH; Rennie CA; Drinkwater AK; Sahu D; Akyol E; Lotery AJ
    Eye (Lond); 2019 Nov; 33(11):1679-1682. PubMed ID: 31028287
    [No Abstract]   [Full Text] [Related]  

  • 12. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).
    Marmor MF; Kellner U; Lai TY; Melles RB; Mieler WF;
    Ophthalmology; 2016 Jun; 123(6):1386-94. PubMed ID: 26992838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New American Academy of Ophthalmology recommendations on screening for hydroxychloroquine retinopathy.
    Marmor MF
    Arthritis Rheum; 2003 Jun; 48(6):1764. PubMed ID: 12794848
    [No Abstract]   [Full Text] [Related]  

  • 14. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy.
    Melles RB; Marmor MF
    JAMA Ophthalmol; 2014 Dec; 132(12):1453-60. PubMed ID: 25275721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Variability of chloroquine and hydroxychloroquine retinopathy among various ethnicities].
    Giocanti-Aurégan A; Couturier A; Girmens JF; Le Mer Y; Massamba N; Barreau E; Audo I;
    J Fr Ophtalmol; 2018 Apr; 41(4):363-367. PubMed ID: 29678344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New trends in early diagnosis of hydroxychloroquine toxic retinopathy.
    Vanderzee G; Tassi D
    Optometry; 2012 May; 83(5):200-7. PubMed ID: 23249122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case Report: Hydroxychloroquine Retinopathy.
    Eldeeb M; Chan EW; Omar A
    Optom Vis Sci; 2018 Jun; 95(6):545-549. PubMed ID: 29787487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RE: Microperimetry and the diagnosis of antimalarial maculopathy.
    Easterbrook M
    Can J Ophthalmol; 2014 Jun; 49(3):307-8. PubMed ID: 24862782
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydroxychloroquine and chloroquine retinopathy: screening for drug toxicity.
    Browning DJ
    Am J Ophthalmol; 2002 May; 133(5):649-56. PubMed ID: 11992862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIMING FOR THE BULL'S EYE: The Cost-Utility of Screening for Hydroxychloroquine Retinopathy.
    McClellan AJ; Chang JS; Smiddy WE
    Retina; 2016 Oct; 36(10):1958-63. PubMed ID: 27465574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.